Indivior Pharmaceuticals, Inc. (INDV) Gross profit 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) annual gross profit history from SEC filings — each fiscal year as reported.
$994.0MFY2025 · since FY2022: $749.0M → $994.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $994.0M | +3.9% |
| FY2024 | $957.0M | +4.1% |
| FY2023 | $919.0M | +22.7% |
| FY2022 | $749.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More INDV financial trends
INDV RevenueINDV Net incomeINDV Net marginINDV Gross marginINDV Operating incomeINDV Operating marginINDV Operating cash flowINDV Free cash flowINDV Capital expendituresINDV Return on equityINDV Stock buybacksINDV Dividends paidINDV Total assetsINDV Total liabilitiesINDV Shareholders’ equityINDV overview →